Cargando…
Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout
The SARS-CoV-2 Delta variant, known as B.1.617.2 and first identified in India, is becoming a dominant strain in many countries due to its extreme infectiousness. Assessing and quantifying the transmissibility and competitive advantage of the Delta variant is of major significance for countries arou...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349563/ https://www.ncbi.nlm.nih.gov/pubmed/34395957 http://dx.doi.org/10.1016/j.idm.2021.08.001 |
_version_ | 1783735588630822912 |
---|---|
author | Xia, Fan Yang, Xinpei Cheke, Robert A. Xiao, Yanni |
author_facet | Xia, Fan Yang, Xinpei Cheke, Robert A. Xiao, Yanni |
author_sort | Xia, Fan |
collection | PubMed |
description | The SARS-CoV-2 Delta variant, known as B.1.617.2 and first identified in India, is becoming a dominant strain in many countries due to its extreme infectiousness. Assessing and quantifying the transmissibility and competitive advantage of the Delta variant is of major significance for countries around the world so that appropriate measures to mitigate and even eliminate the epidemic can be introduced. Aiming at such problems, we proposed a method to model the invasion process of a novel strain and estimate the competitive advantage of the invading strain over the local strain. We applied this method to study the invasion and spread of the Delta variant into England. We have estimated the basic reproduction number of the Delta variant as being 49% higher than that of the Alpha variant (CI: 45–52%), assuming a mean generation interval of 5 days with a standard deviation of 3 days. In the period 11 April to 17 May 2021, the effective reproduction number of the Delta variant was 65% higher than that of the Alpha variant in England (CI: 61–70%). Our results show that the Delta variant has a significantly higher transmission capacity than other strains, which explains the rebound of the epidemic in many countries, even in those with relatively high vaccination coverages. |
format | Online Article Text |
id | pubmed-8349563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-83495632021-08-09 Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout Xia, Fan Yang, Xinpei Cheke, Robert A. Xiao, Yanni Infect Dis Model Original Research Article The SARS-CoV-2 Delta variant, known as B.1.617.2 and first identified in India, is becoming a dominant strain in many countries due to its extreme infectiousness. Assessing and quantifying the transmissibility and competitive advantage of the Delta variant is of major significance for countries around the world so that appropriate measures to mitigate and even eliminate the epidemic can be introduced. Aiming at such problems, we proposed a method to model the invasion process of a novel strain and estimate the competitive advantage of the invading strain over the local strain. We applied this method to study the invasion and spread of the Delta variant into England. We have estimated the basic reproduction number of the Delta variant as being 49% higher than that of the Alpha variant (CI: 45–52%), assuming a mean generation interval of 5 days with a standard deviation of 3 days. In the period 11 April to 17 May 2021, the effective reproduction number of the Delta variant was 65% higher than that of the Alpha variant in England (CI: 61–70%). Our results show that the Delta variant has a significantly higher transmission capacity than other strains, which explains the rebound of the epidemic in many countries, even in those with relatively high vaccination coverages. KeAi Publishing 2021-08-08 /pmc/articles/PMC8349563/ /pubmed/34395957 http://dx.doi.org/10.1016/j.idm.2021.08.001 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Article Xia, Fan Yang, Xinpei Cheke, Robert A. Xiao, Yanni Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
title | Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
title_full | Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
title_fullStr | Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
title_full_unstemmed | Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
title_short | Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
title_sort | quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349563/ https://www.ncbi.nlm.nih.gov/pubmed/34395957 http://dx.doi.org/10.1016/j.idm.2021.08.001 |
work_keys_str_mv | AT xiafan quantifyingcompetitiveadvantagesofmutantstrainsinapopulationinvolvingimportationandmassvaccinationrollout AT yangxinpei quantifyingcompetitiveadvantagesofmutantstrainsinapopulationinvolvingimportationandmassvaccinationrollout AT chekeroberta quantifyingcompetitiveadvantagesofmutantstrainsinapopulationinvolvingimportationandmassvaccinationrollout AT xiaoyanni quantifyingcompetitiveadvantagesofmutantstrainsinapopulationinvolvingimportationandmassvaccinationrollout |